SB3525 mandates coverage for up to a 12-month supply of prescription hormone therapy in Illinois insurance policies.
SB3525 amends various Illinois statutes to require insurance policies to cover up to a 12-month supply of prescription hormone therapy. This applies to policies amended, delivered, issued, or renewed in Illinois after the bill's effective date. Exceptions include cases where the patient requests a smaller supply, the prescribing provider instructs otherwise, a temporary shortage exists, or the therapy is a controlled substance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.